LWACU

Locust Walk Acquisition Corp.

Price

$10.36

return (12m)

2.68%

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

LWACU price

Locust Walk Acquisition

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment LWACU

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.39%

3 months

0.58%

1 year

2.68%

2 years

0.00%

5 years

-40.08%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals LWACU

Valuation

P/E

0.00

Sector -4.26

Industry -4.26

P/BV

0.00

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

0.00

Sector 1.25

Industry 1.25

P/Net Current Assets

0.00

Sector -5.47

Industry -5.47

P/Working Capital

0.00

Sector -1.10

Industry -1.10

EPS

999,999.99

Sector -1.94

Industry -1.94

BVPS

-999,999.99

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-102.34%

Sector -61.50%

Industry -61.50%

ROA

3.31%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.82

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

-0.03

Sector 0.43

Industry 0.43

Liabilities/Assets

0.04

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals LWACU

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
LWACU Locust Walk Acquisition Corp.	$10.36	3.08%	0.00%	0.00	0.00	-102.34%	0.00%
JNJ Johnson & Johnson	$270.50	56.19%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$28.40	22.99%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$261.51	30.02%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-10.75%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$153.67	87.14%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$165.95	6.18%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.68	50.37%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$77.85	-48.70%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$823.41	40.89%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$442.24	55.97%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$108.20	49.84%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$894.24	32.40%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$549.81	41.36%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$237.95	65.02%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.40	5.29%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$220.77	58.47%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

LWACU Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Locust Walk Acquisition

Locust Walk Acquisition Corp.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Locust Walk Acquisition Corp. (United States) is listed on the Nasdaq and has a market capitalization of $10.36 , with shareholders equity totaling $-7.26 million.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Locust Walk Acquisition Corp. reported $- in revenue, generating net income of $7.43 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker LWACU.

Market cap

$10.36

Net worth

$-7.26 million

$-7,260,000.00

Assets

$224.60 million

$224,600,000.00

Total Shares Outstanding

1.00

000

Average Daily Trading Volume

$10.00 million

$10,000,000.00

Sector

Health Care

Industry

Biotechnology

LWACU

LWACU revenue and profits

Financial Results LWACU

DRAG THE FRAME TO SEE MORE DATA

LWACU cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$894.24 32,08% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$237.95 63,39% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$270.50 57,89% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$261.51 29,51% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$153.67 87,85% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$165.95 6,34% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$28.40 24,07% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$894.24 32,08% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$237.95 63,39% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$270.50 57,89% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$261.51 29,51% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$153.67 87,85% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$165.95 6,34% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$28.40 24,07% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Locust Walk Acquisition (LWACU) today?

A cotação de Locust Walk Acquisition (LWACU) hoje está em US$ 10.36, com uma variação de 2.68% em relação ao último ano. A cotação de Locust Walk Acquisition (LWACU) iniciou o ano negociando na casa dos US$ 10.20 e hoje está em US$ 10.36. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Locust Walk Acquisition (LWACU) e dados de ações do Ibovespa e mercados internacionais.

Quando Locust Walk Acquisition (LWACU) paga dividendos?

Locust Walk Acquisition (LWACU) não distribuiu dividendos no último ano.

Is Locust Walk Acquisition (LWACU) a good investment?

Atualmente, Locust Walk Acquisition (LWACU) está cotada a US$ 10.36, com um P/L de 0.00, representando um desvio de 0% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 2.68 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 2.68%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Locust Walk Acquisition (LWACU) stock?

Investir em ações de Locust Walk Acquisition (LWACU) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Locust Walk Acquisition (LWACU) yield today?

A rentabilidade de Locust Walk Acquisition (LWACU) foi de 0.39% no último mês, 2.68% no último ano e -40.08% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Locust Walk Acquisition (LWACU) hoje, o investimento total seria de US$ 1,036.00, com base na cotação atual de US$ 10.36.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 1,063.76
Em 5 anos: US$ 620.77
Em 10 anos: US$ 1,036.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

LWACU

Locust Walk Acquisition Corp.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment LWACU

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING LWACU WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Locust Walk Acquisition

Locust Walk Acquisition Corp.

United States

- year

-

Financial Results LWACU

LWACU cash flow

Asset, Revenue and Profit Growth - LWACU

LWACU balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions